Robert Slinger

1.6k total citations
47 papers, 929 citations indexed

About

Robert Slinger is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert Slinger has authored 47 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 15 papers in Infectious Diseases and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert Slinger's work include Respiratory viral infections research (8 papers), Pneumonia and Respiratory Infections (8 papers) and Streptococcal Infections and Treatments (7 papers). Robert Slinger is often cited by papers focused on Respiratory viral infections research (8 papers), Pneumonia and Respiratory Infections (8 papers) and Streptococcal Infections and Treatments (7 papers). Robert Slinger collaborates with scholars based in Canada, Botswana and United States. Robert Slinger's co-authors include Francis Chan, Wendy Ferris, Frank Chan, Talal Alandejani, Baldwin Toye, Isabelle Gaboury, Marc Desjardins, Jeffrey M. Pernica, Mélanie Duval and David A. Goldfarb and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Journal of Clinical Microbiology.

In The Last Decade

Robert Slinger

46 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Slinger Canada 16 307 197 151 145 139 47 929
S Ringertz Sweden 21 306 1.0× 253 1.3× 37 0.2× 29 0.2× 103 0.7× 52 945
John P. Leeming United Kingdom 30 961 3.1× 422 2.1× 88 0.6× 108 0.7× 185 1.3× 54 2.1k
Neriman Balaban Türkiye 17 337 1.1× 204 1.0× 86 0.6× 36 0.2× 40 0.3× 27 923
Mario J. Marcon United States 24 750 2.4× 421 2.1× 77 0.5× 51 0.4× 116 0.8× 58 1.3k
Araya Gebreyesus Wasihun Ethiopia 16 212 0.7× 251 1.3× 124 0.8× 40 0.3× 27 0.2× 27 733
Azian Harun Malaysia 20 490 1.6× 540 2.7× 79 0.5× 59 0.4× 154 1.1× 81 1.2k
Rosemary C. She United States 23 564 1.8× 418 2.1× 79 0.5× 81 0.6× 101 0.7× 85 1.6k
Shrikala Baliga India 16 152 0.5× 237 1.2× 67 0.4× 28 0.2× 46 0.3× 59 615
Alison Laufer Halpin United States 20 517 1.7× 411 2.1× 217 1.4× 9 0.1× 108 0.8× 84 1.7k
Lisa L. Dever United States 16 232 0.8× 388 2.0× 26 0.2× 62 0.4× 39 0.3× 43 831

Countries citing papers authored by Robert Slinger

Since Specialization
Citations

This map shows the geographic impact of Robert Slinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Slinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Slinger more than expected).

Fields of papers citing papers by Robert Slinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Slinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Slinger. The network helps show where Robert Slinger may publish in the future.

Co-authorship network of co-authors of Robert Slinger

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Slinger. A scholar is included among the top collaborators of Robert Slinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Slinger. Robert Slinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
King, Simon, Kyle Briggs, Robert Slinger, & Vincent Tabard‐Cossa. (2022). Screening for Group A Streptococcal Disease via Solid-State Nanopore Detection of PCR Amplicons. ACS Sensors. 7(1). 207–214. 21 indexed citations
3.
Slinger, Robert, et al.. (2020). Pragmatic evaluation of a midstream urine collection technique for infants in the emergency department. Canadian Journal of Emergency Medicine. 22(5). 665–672. 7 indexed citations
5.
Slinger, Robert, et al.. (2018). A comparison of the Allplex™ bacterial and viral assays to conventional methods for detection of gastroenteritis agents. BMC Research Notes. 11(1). 514–514. 12 indexed citations
6.
Pernica, Jeffrey M., April Kam, Jacob Bailey, et al.. (2018). Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial. Trials. 19(1). 83–83. 2 indexed citations
8.
Slinger, Robert, et al.. (2014). Direct Streptococcus pneumoniae real-time PCR serotyping from pediatric parapneumonic effusions. BMC Pediatrics. 14(1). 189–189. 14 indexed citations
9.
Wang, Bing, Kathryn Bernard, Nancy Stewart, et al.. (2012). Staphylococcus Lugdunensis. The Pediatric Infectious Disease Journal. 32(1). 87–89. 7 indexed citations
10.
Slinger, Robert, et al.. (2011). Rapid PCR detection of group a streptococcus from flocked throat swabs: A retrospective clinical study. Annals of Clinical Microbiology and Antimicrobials. 10(1). 33–33. 24 indexed citations
11.
Kilty, Shaun, Mélanie Duval, Francis Chan, Wendy Ferris, & Robert Slinger. (2011). Methylglyoxal: (active agent of manuka honey) in vitro activity against bacterial biofilms. International Forum of Allergy & Rhinology. 1(5). 348–350. 77 indexed citations
12.
Ramotar, Karam, Katherine L. Vandemheen, Elizabeth Tullis, et al.. (2007). Infection With Burkholderia cepacia Complex Bacteria and Pulmonary Exacerbations of Cystic Fibrosis. CHEST Journal. 131(4). 1188–1196. 15 indexed citations
13.
Slinger, Robert, et al.. (2007). Pyrosequencing™ of a recA gene variable region for Burkholderia cepacia complex genomovar identification. Diagnostic Microbiology and Infectious Disease. 58(4). 379–384. 8 indexed citations
14.
Slinger, Robert, et al.. (2006). Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilms. Diagnostic Microbiology and Infectious Disease. 56(3). 247–253. 70 indexed citations
16.
Slinger, Robert, Marc Desjardins, Anne McCarthy, et al.. (2004). Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series. BMC Infectious Diseases. 4(1). 36–36. 58 indexed citations
17.
Slinger, Robert, et al.. (2002). Nosocomial Influenza at a Canadian Pediatric Hospital From 1995 to 1999: Opportunities for Prevention. Infection Control and Hospital Epidemiology. 23(10). 627–629. 16 indexed citations
18.
Slinger, Robert. (2001). How to assess new treatments. Western Journal of Medicine. 174(3). 182–186. 4 indexed citations
19.
Slinger, Robert, Susan G Mackenzie, & Martin Tepper. (2000). Community-acquired needle stick injuries in Canadian children: Review of Canadian Hospitals Injury Reporting and Prevention Program data from 1991 to 1996. Paediatrics & Child Health. 5(6). 324–328. 8 indexed citations
20.
Slinger, Robert, et al.. (1999). Transfusion-transmitted malaria in Canada.. PubMed. 25(6). 53–62. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026